Skip to main content

John J. Strouse

Associate Professor of Medicine
Medicine, Hematology

Selected Grants


Sickle Cell Disease Functional Assessment Validation and Exercise Pilot Intervention

ResearchMentor · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2028

Achieving Understanding of the Natural history of sickle cell Trait (AUNT)

ResearchPrincipal Investigator · Awarded by National Alliance for Sickle Cell Centers · 2024 - 2026

Hematology & Transfusion Medicine (T32)

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1975 - 2026

Cure Sickle Cell

Clinical TrialPrincipal Investigator · Awarded by Medical College of Wisconsin · 2022 - 2025

Education and Mentoring to Bring Access to Comprehensive Care (EMBRACE) Network

Public ServicePrincipal Investigator · Awarded by University of Alabama at Birmingham · 2017 - 2025

Environmental Modifiers of Severity in Children with Sickle Cell Anemia (EMS-SCA)

ResearchPrincipal Investigator · Awarded by ASH Registry Inc d/b/a ASH Research Collaborative · 2024 - 2025

Central Carolinas Clinical Trials Collaboration (C3TC)

ResearchPrincipal Investigator · Awarded by American Society of Hematology · 2021 - 2025

NC DHHS Sickle Cell Contract

Public ServicePrincipal Investigator · Awarded by NC DHHS · 1999 - 2025

Hydroxyurea Pharmacokinetics and Pharmacodynamics in Adults with Sickle Cell Anemia

ResearchPrincipal Investigator · Awarded by Rhode Island Hospital · 2022 - 2024

North Carolina Sickle Cell Data Collection

Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2024 - 2024

1/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)

Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2018 - 2024

COVID-19 Vaccine Response in People Living with Sickle Cell Disease

Clinical TrialPrincipal Investigator · Awarded by American Society of Hematology · 2022 - 2024

Characterizing frailty in older adults with sickle cell disease using a sickle cell frailty index (FI-SCD)

ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2023

NCDHHS Sickle Cell Data Collection Program in North Carolina Year 3

Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2022 - 2023

PRIDE-Functional and Translational Genomics of Blood Disorders

ResearchMentor · Awarded by Augusta University · 2021 - 2023

Sickle Cell Data Collection Program in North Carolina - Optional

Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2021 - 2022

Sickle Cell Data Collection Program in North Carolina

Public ServiceCo Investigator · Awarded by NC Department of Health and Human Services · 2021 - 2022

2020 ASH RTAF

ResearchPrincipal Investigator · Awarded by American Society of Hematology · 2020 - 2021

Capacity Building for Sickle Cell Disease Surveillance in North Carolina (Component A)

ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2019 - 2020

2019 ASH RTAF

ResearchPrincipal Investigator · Awarded by American Society of Hematology · 2019 - 2020

Understanding the Intersection of Stigma and Self-Management in Sickle Cell Disease

FellowshipSponsor · Awarded by National Institutes of Health · 2017 - 2019

Sickle Cell Treatment Demonstration

ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2016 - 2017

External Relationships


  • American Society of Hematology
  • Bendin Sumrall & Ladner, llc
  • Coleman Research
  • Disc Medicine
  • EBSCO Health / DynaMed Plus
  • Editas Medicine
  • ExpertConnect
  • Frontiers
  • GLG
  • Guidepoint Global
  • National Vaccine Injury Compensation Program
  • UpToDate, Inc

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.